Home
    Disclaimer
    ๐Ÿงช This is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.
    โš  Opioids carry significant risk of respiratory depression, physical dependence, and fatal overdose. Never combine with other depressants.

    Methoxypiperamide Limited data
    Limited data
    Sparse data. Doses and effects may be unreliable or untested.
    • 2 corroborating sources
    • no dose data
    • duration data present
    • 19 combo interactions documented
    • classified Research-chemical

    Summary TripSit

    Drug of the Piperazine class. The 4-Methoxy-ฮฑ-keto analogue of Methylbenzylpiperazine. Seemingly inactive on its own.

    Dose Information

    No curated dose ladder is available for this substance. The figures below are drawn from SubstanceIndex (DoseWiki) as a fallback — often a conservative threshold only. Treat them as approximate and cross-reference before use.

    Light Common Strong Heavy

    Onset, Duration & After-effects

    Effect Profile

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Opioid 1.9
    Light 2/10

    Low sedation

    Euphoria / Warmth ×3
    0
    Analgesia ×2
    0
    Sedation / Relaxation ×1
    3
    sedation
    Itching / Nausea ×1
    0

    Tolerance

    Build-up develops within days of regular use; analgesic tolerance faster than respiratory depression tolerance
    Reset 7โ€“14 days for partial reset; full reset may take weeks โ€” tolerance loss greatly increases overdose risk

    Tolerance Decay

    Full tolerance 1d Half tolerance 21d Baseline ~35d

    Effects

    Negative
    • Motor impairment
    Neutral
    • Sedation
    Positive
    • Reduced anxiety
    Neutral
    • Dulled perception

    Combinations TripSit

    Cross-Check Methoxypiperamide with another substance

    Helpful Links